Hired and retired: Gilead, Amgen, and Tenaya change execs By Flora Southey 31-Jul-2018 - Last updated on 31-Jul-2018 at 15:38 GMT Facebook Twitter Linkedin Email to a friend (Image: Getty/AndreyPopov Gilead Sciences CEO steps down, Amgen SVP of translational sciences steps up, and ex-bluebird bio executive joins Tenaya Therapeutics. Biopharma-Reporter catches you up on the latest industry hires in the large molecule space. Hired and retired: Gilead, Amgen, and Tenaya change execs Gilead Sciences: John Milligan Amgen: Sean Harper Amgen: David Reese IO Biotech: Kathleen Glaub Tenaya Therapeutics: Faraz Ali CANbridge: Janny Wang Prev 1 2 3 4 5 … 7 Next
